Clin Exp Otorhinolaryngol.  2018 Jun;11(2):96-101. 10.21053/ceo.2017.00948.

Clinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo

• Park MJ
• Kim SH
• Kim SS
• Yeo SG

• KMID: 2412666
• DOI: http://doi.org/10.21053/ceo.2017.00948

Abstract

OBJECTIVES
This study analyzed short-term prognosis in patients with acute low frequency hearing loss (ALHL), and also investigate hearing recovery rates in patients with ALHL accompanied vertigo.
METHODS
Retrospective medical record review of the patients who received treatment for ALHL between June 2005 and June 2015 were analyzed. Of the 84 patients, 53 were without vertigo, and 31 were with vertigo. Of the 31 patients, eight were treated with steroids, seven with diuretics alone, and 16 with both. Clinical and auditory characteristics before and after treatment were compared in these three groups.
RESULTS
Pure tone audiometry after 8 weeks of treatment showed that patients with vertigo had significantly higher than patients without vertigo (P=0.020). Patients with vertigo who recovered from ALHL had a greater tendency to receive early treatment than patients who did not recover. Patients who received the two steroid therapy groups (steroids alone and steroids plus diuretics) had a higher recovery rate than patients who received diuretics alone (P=0.043 and P=0.037, respectively).
CONCLUSION
The prognosis of patients with ALHL is worse in those with vertigo compared to without vertigo. The hearing recovery rate in patients with vertigo tends to be higher in those treated with steroids than with diuretics alone.

Keyword

Low Frequency Hearing Loss; Vertigo; Steroids; Diuretics

MeSH Terms

Audiometry
Diuretics
Hearing
Hearing Loss
Hearing Loss, Sensorineural*
Humans
Medical Records
Prognosis
Retrospective Studies
Steroids
Vertigo*
Diuretics
Steroids

Figure

• 

  Fig. 1. Low tone hearing levels in patients with acute low frequency hearing loss and vertigo before and after 8 weeks of treatment. Tx, treatment; DI, diuretics.

• 

  Fig. 2. Distribution of audiologic responses after 8 weeks of treatment in patients with acute low frequency hearing loss accompanied vertigo DI, diuretics. *Significant difference between groups, P<0.05.

Reference

1. Abe T. Acute sensorineural hearing loss in low tone frequencies. Otolaryngology (Tokyo). 1982; 54:385–92.

2. Kwak MY, Yu KK, Kang YK, Yoon SW, Shim HJ, An YH. Intratympanic steroid and oral diuretics combination therapy for acute low frequency sensorineural hearing loss without vertigo. Korean J Otorhinolaryngol Head Neck. 2015; Jan. 58(1):19–24.

3. Fuse T, Aoyagi M, Funakubo T, Sakakibara A, Yoshida S. Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid. ORL J Otorhinolaryngol Relat Spec. 2002; Jan-Feb. 64(1):6–10.

4. Chen CN, Young YH. Differentiating the cause of acute sensorineural hearing loss between Meniere’s disease and sudden deafness. Acta Otolaryngol. 2006; Jan. 126(1):25–31.

5. Bespalova IN, Van Camp G, Bom SJ, Brown DJ, Cryns K, DeWan AT, et al. Mutations in the Wolfram syndrome 1 gene (WFS1) are a common cause of low frequency sensorineural hearing loss. Hum Mol Genet. 2001; Oct. 10(22):2501–8.

6. Imamura S, Nozawa I, Imamura M, Murakami Y. Clinical observations on acute low-tone sensorineural hearing loss: survey and analysis of 137 patients. Ann Otol Rhinol Laryngol. 1997; Sep. 106(9):746–50.

7. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977; Jul-Aug. 86(4 Pt 1):463–80.

8. Morita S, Suzuki M, Iizuka K. A comparison of the short-term outcome in patients with acute low-tone sensorineural hearing loss. ORL J Otorhinolaryngol Relat Spec. 2010; Oct. 72(6):295–9.

9. Suzuki M, Otake R, Kashio A. Effect of corticosteroids or diuretics in low-tone sensorineural hearing loss. ORL J Otorhinolaryngol Relat Spec. 2006; Apr. 68(3):170–6.

10. Stachler RJ, Chandrasekhar SS, Archer SM, Rosenfeld RM, Schwartz SR, Barrs DM, et al. Clinical practice guideline: sudden hearing loss. Otolaryngol Head Neck Surg. 2012; Mar. 146(3 Suppl):S1–35.

11. Whitaker S. Idiopathic sudden hearing loss. Am J Otol. 1980; Jan. 1(3):180–3.

12. Yamasoba T, Kikuchi S, Sugasawa M, Yagi M, Harada T. Acute low-tone sensorineural hearing loss without vertigo. Arch Otolaryngol Head Neck Surg. 1994; May. 120(5):532–5.

13. Wu CL, Young YH. Vestibular evoked myogenic potentials in acute low-tone sensorineural hearing loss. Laryngoscope. 2004; Dec. 114(12):2172–5.

14. Fushiki H, Junicho M, Aso S, Watanabe Y. Recurrence rate of idiopathic sudden low-tone sensorineural hearing loss without vertigo: a long-term follow-up study. Otol Neurotol. 2009; Apr. 30(3):295–8.

15. Hillman TM, Arriaga MA, Chen DA. Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops? Laryngoscope. 2003; Nov. 113(11):1903–7.

16. Junicho M, Aso S, Fujisaka M, Watanabe Y. Prognosis of low-tone sudden deafness: does it inevitably progress to Meniere’s disease? Acta Otolaryngol. 2008; Mar. 128(3):304–8.

17. Oishi N, Inoue Y, Saito H, Kanzaki S, Kanzaki J, Ogawa K. Long-term prognosis of low-frequency hearing loss and predictive factors for the 10-year outcome. Otolaryngol Head Neck Surg. 2010; Apr. 142(4):565–9.

18. Luque AE, Orlando MS, Leong UC, Allen PD, Guido JJ, Yang H, et al. Hearing function in patients living with HIV/AIDS. Ear Hear. 2014; Nov-Dec. 35(6):e282–90.

19. Fuse T, Hayashi T, Oota N, Fukase S, Asano S, Kato T, et al. Immunological responses in acute low-tone sensorineural hearing loss and Meniere’s disease. Acta Otolaryngol. 2003; Jan. 123(1):26–31.

20. Greenberg SL, Nedzelski JM. Medical and noninvasive therapy for Meniere’s disease. Otolaryngol Clin North Am. 2010; Oct. 43(5):1081–90.